The effect on in vivo tumor growth was modest, possibly because miR205HG influences only early stages of tumorigenesis; however, a Gli reporter construct measuring SHH-signaling activity in miR205HG-stably transfected cells may potentially provide stronger direct evidence that miR205HG targets SHH and shuts down the entire signaling pathway. The gene discussed is GLI1; the disease is neoplasm.